Dutch Pleco Therapeutics BV has raised €17.3m in a Series A financing to push its lead candidate in acute myeloid leukaemia to market approval.
Synaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence.
Abivax SAParis-based Abivax SA has cashed in €49.2m in an oversubscribed financing with top-tier US and European biotech investors.
German nucleic acid extraction specialist BioEcho Life Sciences has opened a subsidiary in Boston to supply the huge US-american market.
Researchers from KU Leuven for the first time have produced human cells able to mimic the molecular mechanisms of early human embryogenesis and related defects.
A small prospective study among mid-aged people has demonstrated that a mild SARS-CoV-2 infection triggers ME/CF in 50% of the study population.<button lang="en-GB" aria-description="Klicken, um Alternative zu verwenden">
</button>
Swedish food and feed supplement specialist Bactolife A/S has received US$5m in funding from the Bill & Melinda Gates Foundation to address gastrointestinal infections.
For the second time within a short period of time, a competitor has sued the mRNA vaccine developer BioNtechPfizer for patent infringement.
Moderna co-founder Kenneth Chien and Novalis LifeSciences LLC are the lead investors of a €39m Series B2 financing in eTheRNA.
Kinarus Therapeutics Holding AG has raised US$20m in financing through the issuance of convertible bonds to YA II PN, Ltd.